Develops instruments for researchers who desire to directly measure material aspects of tissue quality using clinically relevant technology. BioDent™ is a versatile (in vivo / ex vivo) bench-top instrument for measuring hard and soft tissues. OsteoProbe® is a hand-held instrument utilized by clinical researchers for measuring bone in vivo.
Alexion develops and delivers life-transforming therapies for patients with devastating and rare diseases. Alexion is establishing a global metabolic rare disease franchise that includes two late-stage therapies, asfotase alfa for hypophosphatasia (HPP) and sebelipase alfa for lysosomal acid lipase deficiency (LAL-D), while advancing the most robust rare disease pipeline in the biotech industry.
ALPCO offers a wide range of testing solutions, providing scientists and healthcare professionals with vital tools for advancing research and improving quality of care. Our product portfolio includes applications for immunoassays, HPLC, LC-MS/MS, purified antibodies, recombinant proteins, flow cytometry reagents and our new STELLUXTH chemiluminescent assay platform.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Biomedica Immunoassays provides internationally recognized, high quality biomarker ELISAs with serum-based calibrators and controls for clinical research for Sclerostin, Osteoprotegerin, DKK-1 and FREE soluble RANKL. Biomedica’s customers include numerous top ranking scientific institutions worldwide, well-known CROs, and laboratories in the pharmaceutical industry. Visit us for additional information. (www.bmgrp.com).
Discover the BIOQUANT OSTEO software for automatic skeletal phenotyping. Additional histomorphometry and microCT protocols support research in fracture repair, arthritis, cancer metastasis, implants, and muscle phenotyping. To create digital slides, use your own digital pathology scanner, your own digital camera, or one of our slide-scanning upgrade kits for your microscope.
Bruker offers advanced preclinical imaging solutions for a broad spectrum of application fields, including orthopedics. Drawing on over twenty years’ experience, Bruker develops and manufactures systems for 3-dimensional, non-destructive investigation of an object’s internal microstructure.
Carl Zeiss X-ray Microscopy introduces two new non-destructive 3D x-ray imagining systems for life sciences. The ZEISS Xradia 520 Versa, offers submicron imaging and ZEISS Xradia 810, provides <50 nm spatial resolution, expands your views in developmental biology with high resolution, high contrast images of cellular and subcellular structures.
Charles River offers musculoskeletal research services that combine discovery and preclinical program development with novel research technologies to provide specialized evaluations of bone disease and bone quality. Our scientists can assess the effects of a drug at toxicological and pharmacological doses and provide consultation on study design and project execution.
Clementia is a clinical-stage biopharmaceutical company focused on bringing treatment to those affected by rare disease. Clementia is advancing palovarotene to address fibrodysplasia ossificans progressiva (FOP) and other diseases. A Phase 2 clinical trial is currently evaluating the long-term safety and efficacy of palovarotene in individuals with FOP.
DIAsource ImmunoAssays, an international diagnostic company based in Belgium, develops, manufactures and markets clinical diagnostic products in the field of endocrinology and infectious diseases. Since 1997, Future Diagnostics has been leading in assay development and manufacturing services to the medical diagnostics and device industries.
As your access point into the recent advancements in bone and mineral research, Elsevier provides cutting-edge research from worldwide experts. Explore the latest research findings in our leading journals; Bone, Bone Reports, and Journal of Clinical Densitometry. Our exciting books on display include Osteoimmunology, Genetic Diagnosis of Endocrine Disorders, and more. Discover our electronic research and solution tools on ScienceDirect!
EMD Millipore is the Life Science division of Merck KGaA of Germany, supporting research, development and production of biotech and pharmaceutical drug therapies. We support cellular analysis, pathway elucidation and functional genomics with the most relevant multiplex assays, complete range of instruments and software for analyzing bone metabolism biomarkers.
The Endocrine Society is the world’s oldest, largest, and most active organization devoted to research on hormones and the clinical practice of endocrinology. The Society’s membership consists of over 16,000 scientists, physicians, educators, nurses and students in more than 100 countries and members represent all basic, applied, and clinical interests in endocrinology.www.endocrine.org.
GE Healthcare provides transformational medical technologies that are shaping a new age of patient care. Our expertise in medical imaging, patient monitoring and biopharmaceutical manufacturing technologies is helping clinicians re-imagine ways to treat disease. GE offers bone densitometry solutions to protect the vitality of your patients.
Horizon Pharma plc is a specialty biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets seven medicines through its orphan, primary care and specialty business units. Horizon’s global headquarters are in Dublin, Ireland.
Immundiagnostik is an internationally active diagnostics company that develops and produces innovative immunoassays and other analytical methods for clinical routine and life science research. We provide effective tools for prevention, differential diagnosis and therapy monitoring in the areas of disorders of the skeletal system, oxidative stress, gastroenterology and cardiovascular diseases.
FGF-23 ELISA test kits for use in humans and mouse/rat samples along with test kits for several forms of PTH, Osteocalcin, Calcitonin and related peptides are developed and manufactured by Immutopics. The company specializes in innovative assays for assessing calcium and phosphate regulation. Since 1989, it has been a leading source of immunoassay kits for pre-clinical studies of bone and mineral disorders in human, rat, mouse and other mammalian models.
Kubtec breaks new ground with Parameter 3D, the 2D/3D cabinet X-ray system with tomosynthesis capability for research applications. Offering unprecedented high-resolution, high-contrast imaging with multi-slice capability, Parameter 3D is the most powerful radiographic tool for research. Parameter 3D joins Kubtec’s expanding line of imaging systems including DIGIMUS allowing BMD measurements.
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded in 1876 by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission. To learn more, visit www.lilly.com.
The Lymphangiomatosis & Gorham's Disease Alliance, www.lgdalliance.org is a patient-support foundation for those affected by generalized lymphatic anomaly and Gorham-Stout disease. We work closely with our partner, the Lymphatic Malformation Institute www.lmiresearch.org, to support research and studies to determine etiology and to develop new therapies.
Founded in Germany in 1951, medi GmbH & Co. KG has become one of the world's leading manufacturers of medical aids. Thanks to the dedication of our international distribution partners and 1700 employees, the company exports to over 90 countries worldwide.
Medimaps mission is to design and provide medical tools to assist in the collection of quantitative information on bone microarchitecture for use in routine clinical practice. We enhance osteoporosis diagnosis by bringing the bone texture dimension to overall fracture risk assessment and patient management in daily practice.
Today's Merck is working to help the world be well. Through our medicines, vaccines, biologic therapies, and consumer and animal products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. Merck. Be Well. For more information, visit www.merck.com.
Micro Photonics, and partner Bruker MicroCT are leading the advancement in high resolution micro-CT solutions for bone, biomaterials, orthopedics, and other life science research with a focus on bone morphology and BMD. The SkyScan product line meets the high-resolution and versatility required for any demanding research laboratory.
Mindways introduces the next generation of QCT: Asynchronous QCT. Asynchronous QCT does not require a patient phantom. It expedites conventional QCT and allows opportunistic and dual-use QCT—the capability to obtain no-dose BMD measurements from CT scans done for other indications—thereby providing an opportunity to greatly increase osteoporosis screening.
The mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases is to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in these diseases.
Galileo/VibraFlex series are patented vibration systems designed to improve muscle strength, power, mobility through improved neuromuscular coordination. Since stronger muscles mean stronger bones, our pQCT technology is valuable in monitoring such improvements. XCTs are bone diagnostic & monitoring devices making three-dimensional assessments of cortical and trabecular bone in one evaluation.
The Osteogenesis Imperfecta Foundation is the only national voluntary health agency dedicated to helping people and families manage osteogenesis imperfecta. The OI Foundation's mission is to improve the quality of life for individuals affected by OI through research to find treatments and a cure, education, awareness and mutual support.
With 350 OsteoMeasure systems worldwide, OsteoMetrics has been redefining Bone Histomorphometry since 1989. The system of choice, OsteoMeasure is now available with live digital camera support, on-screen pen measurement, thresholding, a complete set of Cortical Bone measurements, a greatly expanded set of non-specific measurements, and a comprehensive GLP validation package.
Learn more about pathway characterization, therapeutic effect, and treatment with PerkinElmer’s imaging and analysis solutions for bone and mineral research. Our intuitive, high-performance software, broad portfolio of reagents including OsteoSense™ bisphosphonate in vivo fluorescent imaging agent, and leading imaging systems enable you to see and understand more in the area of bone research.
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.
PharmaLegacy is a preclinical specialty CRO that has strong track records in services to worldwide companies committing R & D in therapeutics for Bone Safety/ Metabolism/Orthopaedics and Tissue Engineering, besides Immune Diseases/Inflammation and Tumor. We provide quality, timely and cost saving execution for experiments under GLP operation and AAALAC certification.
Pharmatest Services Ltd is a preclinical CRO offering efficacy services to the pharmaceutical industry in the fields of skeletal diseases and oncology. We are specialized in bone research and our service products include in vitro bone cell assays (osteoclasts and osteoblasts) and in vivo models of osteoporosis, osteoarthritis and cancer-induced bone disease.
Radius is a science-driven biopharmaceutical company developing new therapeutics for patients with advanced osteoporosis as well as other serious endocrine-mediated diseases. Radius' lead development candidate is the investigational drug abaloparatide for subcutaneous injection, which is completing Phase 3 for the reduction of fracture risk in postmenopausal women with severe osteoporosis.
The Rare Bone Disease Patient Network is a group of organizations that address rare bone diseases. The mission of the Network and of each individual organization is to distribute information to patients, caregivers, physicians and other health professionals and to increase research on rare bone diseases.
Our new product "TRI/3D-BON-FCS" measures 3D morphometry, BMD and bone strength using DICOM files and CT images. "TRI/3D-BON-FCS" enables to qualify the bone formation, bone resorption, and bone destruction. Our software will assist you by analyzing bone lesion and gene expression in bones.
Research Diets, Inc. formulates and produces purified OpenSource Diets® for laboratory animals. Custom diets shipped in 5-7 days. BioDAQ® Food and Liquid Intake Monitor for mice and rats mounts to home cage, records the time, duration, amount of each meal automatically. BioDAQ NHP monitors food intake of socially housed NHPs.
Scanco Medical (www.microCT.com) in the leading manufacturer of state-of-the-art x-ray micro-CT (in vitro and in vivo) and the XtremeCT scanners. The scanners, together with built-in analysis and visualization software provide for a 3-dimensional quantitative measurements. Scanco Medical also offers contract based micro-CT scanning services for academic and industrial groups.
Shire enables people with life-altering conditions to lead better lives. Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.
Soft Bones Foundation provides information and a community to educate, empower and connect patients living with hypophosphatasia (HPP), their families and caregivers. The Foundation also promotes research of this rare bone disease through awareness and fund-raising efforts.
Your success is our mission at TA|ElectroForce®. We provide mechanical testing, characterization, and tissue growth solutions to researchers worldwide. Our ElectroForce® zero-friction motor technology provides exceptional performance and simplicity for sterile and non-sterile applications. Visit our booth to learn more about our biomedical instruments, including the NEW 3DCulturePro™ bioreactor.
Ultragenyx is a clinical-stage biotechnology company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on debilitating genetic diseases. KRN23 is in development as a recombinant fully human monoclonal antibody designed to block the activity of excess FGF23 in XLH
VTS, the world's first animal bone and tissue bank, offers customizable processing and packaging of graft materials for a wide variety of animal models. Researchers can rely on VTS to produce animal tissues processed to their unique product development or pre-clinical project specifications - on time and on budget.